Activity of antibiotics against Fusarium and Aspergillus

British Journal of Ophthalmology

Volumn 93, Issue 1, 2009, Pages 116-119

  Day, S ^a   Lalitha, P ^b   Haug, S ^a   Fothergill, A W ^c   Cevallos, V ^a   Vijayakumar, R ^b   Prajna, N V ^b   Acharya, N R ^a   McLeod, S D ^a   Lietman, T M ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ARAVIND EYE HOSPITAL   (India)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^d Proctor Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; BENZALKONIUM CHLORIDE; CEFAZOLIN; CHLORAMPHENICOL; CIPROFLOXACIN; DEXAMETHASONE PLUS TOBRAMYCIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); GATIFLOXACIN; MOXIFLOXACIN; NATAMYCIN; POLYTRIM; TOBRAMYCIN; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; BROTH DILUTION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FUNGUS ISOLATION; FUSARIUM; HUMAN; INDIA; KERATOMYCOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CORNEAL ULCER; DRUG RESISTANCE, FUNGAL; EYE INFECTIONS, FUNGAL; FEMALE; FUSARIUM; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; MYCOSES; PROSPECTIVE STUDIES;

EID: 58349090226     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.142364     Document Type: Article

References (19)

1. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004;15:321-7.
2. Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol 1997;81:965-71.
3. Bharathi MJ, Ramakrishnan R, Vasu S, et al. Aetiological diagnosis of microbial keratitis in South India-A study of 1618 cases. Indian J Med Microbiol 20:19-24.
4. Ou Jl, Acharya NR. Epidemiology and treatment of fungal corneal ulcers. Int Ophthalmol Clin 2007;47:7-16.
5. Hariprasad SM, Mieler WF, Lin TK, et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol 2008;92:871-8.
6. Khor W, Aung T, Saw S, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA 2006;295:2867-73.
7. Munir WM, Rosenfeld SI, Udell I, et al. Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy. Cornea. 2007;26:621-4.
8. Srinivasan M, Upadhyay MP, Priyadarsini B, et al. Corneal ulceration in south-east Asia III: prevention of fungal keratitis at the village level in south India using topical antibiotics. Br J Ophthalmol 2006;90:1472-5.
9. Chodosh J, Miller D, Tu EY, et al. Tobramycin-responsive Fusarium oxysporum keratitis. Can J Ophthalmol 2000;35:29-30.
10. Ozdek SC, Miller D, Flynn PM, et al. In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections. Ocul Immunol Inflamm 2006;14:347-51.
11. Mehta A, Chopra S, Mehta P. Antibiotic inhibition of pectolytic and cellulolytic enzyme activity in two Fusarium species. Mycopathologia 1993;124:185-8.
12. Alfonso E, Miller D. Impact of 4th generation fluoroquinolones on growth rate and detection time of fungal pathogens [abstract]. Invest Ophthalmol Vis Sci 2005;46:E-Abstract 2766.
13. Chai SJ, Johnson BE, Wilhelmus KR. In vitro effects of moxifloxacin and voriconazole in inhibiting the growth of Fusarium [abstract]. Invest Ophthalmol Vis Sci 2007;48:E-Abstract 2679.
14. Lalitha P, Shapiro BL, Srinivasan M, et al. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol 2007;125:789-93.
15. NCCLS. Reference method for broth dilution antifungal susceptiblity testing of filamentous fungi; approved standard. NCCLS document M38-A. Wayne: Clinical and Laboratory Standards Institute; 2002.
16. Dalhoff A. Pleiotropic actions of aminoglycosides. Antibiot Chemother 1987;39:182-204.
17. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999;12:147-79.
18. Tortorano AM, Viviani MA, Biraghi E, et al. In vitro testing of fungicidal activity of biocides against Aspergillus fumigatus. J Med Microbiol 2005;54:955-7.
19. Rex JH, Pfaller MA. Has antifungal susceptibility testing come of age? Clin Infect Dis 2002;35:982-9.